Impact of peginterferon beta-1a treatment and disease factors on risk of physical deterioration in patients with multiple sclerosis: ADVANCE study

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: cbc483b0bd0202036bd77359d92b9976b6448d01
First added on: Apr 30, 2026